BSBM7
CAS No. 6968-11-2
BSBM7( —— )
Catalog No. M22384 CAS No. 6968-11-2
BSBM7 is an inhibitor of Aβ aggregation and neuronal toxicity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 26 | In Stock |
|
Biological Information
-
Product NameBSBM7
-
NoteResearch use only, not for human use.
-
Brief DescriptionBSBM7 is an inhibitor of Aβ aggregation and neuronal toxicity.
-
DescriptionBSBM7 is an inhibitor of Aβ aggregation and neuronal toxicity.
-
In VitroAmino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetBeta Amyloid
-
RecptorAβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6968-11-2
-
Formula Weight508.56
-
Molecular FormulaC22H24N2O8S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)[C@H](CSSC[C@H](NC(=O)OCc1ccccc1)C(O)=O)NC(=O)OCc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Astrophloxine
Astrophloxine is a fluorescent imaging probe that targets antiparallel dimers and can be used to detect aggregated Aβ in brain tissue and cerebrospinal fluid samples from Alzheimer's disease (AD) mice.
-
β-Amyloid 29-40
β-Amyloid (29-40) is a fragment of Amyloid-β peptide.Alzheimer's beta amyloid peptide (29-40/42) C-terminal fragments have physical and chemical properties related to those of fusion peptides of viral proteins. The fusion of liposomes can be induced by these peptides in vitro.
-
β-Amyloid 11-22
β-Amyloid (11-22) is a peptide fragment of β-Amyloid.Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s patients, is thought to be the cause of Alzheimer’s Disease (AD). AD is the most common neurodegenerative disease and afflicts about 10% of the population over 60.
Cart
sales@molnova.com